References
- Fuchs J, Podda M, Rachmilewitz E. Oxidative imbalance in hereditary hemoglobinopathies: The role of reactive oxygen species in pathophysiology of sickle cell anemia and thalassemia. In: Fuchs J, Ed. Redox Genome Interactions in Health and Disease. New York: CRC Press. 2003:305–322
- Hageman JJ, Bast A, Vermeulen N. Monitoring of oxidative free radical damage in vivo: Analytical aspects. Chem Biol Interact. 1992;82(3):243–293
- Esterbauer H, Schaur RJ, Zolner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Rad Biol Med. 1991;11(1):81–128
- Schrier SL, Centis F, Verneris M, et al. The role of oxidant injury in the pathophysiology of human thalassemias. Redox Rep. 2003;8(5):241–245
- Handayani S, Adhiyanto C, Fani IR, et al. Imbalanced antioxidant status in transfusion-dependent thalassemia patients in Jakarta, Indonesia. In: Packer L, Nasaretnam K, Eds. Micronutrients and Health-Molecular Biological Mechanisms. Urbana: AOCS Press. 2001:290–298
- Kusano C, Ferrari B. Total antioxidant capacity: A biomarker in biomedical and nutritional studies. J Cell Mol Biol. 2008;7(1):1–15
- Posteraro A Jr, Gottfried EL. The diagnostic significance of a prolonged erythrocytic glycerol lysis time (GLT50). Am J Clin Pathol. 1978;70(4):637–641
- Deledda R, Russino G, Inzaina A. Evaluation of globular osmotic resistance (GOR) and of the lysis test with glycerol (GLT50) in the screening of heterozygous thalassemia. Quad Sclavo Diagn. 1978;14(2):259–265
- Rajnoldi AC, Ferrari M, Pietri S, Travi M. Glycerol lysis time for screening for β-thalassemia trait. Lancet. 1980;2(8195 pt 1):638
- Cighetti G, Duca L, Bortone L, et al. Oxidative status and malondialdehyde in β-thalassemia patients. Eur J Clin Inves. 2002;32(1):55–60
- Kuypers FA. Membrane lipid alterations in hemoglobinopathies. Hematology Am Soc Hematol Educ Program. 2007:68–73
- Hattori Y, Yamashiro Y, Okayama N, et al. Characteristic of Japanese thalassemia. Int J Hum Genet. 2003;3(4):259–267
- Nadkarni AH, Nair SB, Italia KY, et al. Molecular diversity of Hemoglobin H disease in India. Am J Clin Pathol. 2010;133(3):491–494
- Kahane J, Rachmilewitz EA. Alteration in the red blood cell membrane and the effect of vitamin E on osmotic fragility in β-thalassemia major. Isr J Med Sci. 1976;12(1):11–15
- Benga G. Water channels proteins (later called aquaporins) and relatives: Past, present and future. IUBMB Life. 2009;61(2):112–133
- McMillan DC, Powell CL, Bowman ZS, et al. Lipids versus protein as major targets of pro-oxidant, direct-acting haemolytic agents. Toxicol Sci. 2005;88(1):274–283
- Henzler TQYE, Steudle E. Oxidative gating of water channels (aquaporins) in Chara by hydroxyl radicals. Plant Cell Environ. 2006;29(4):459–470
- Martins AP, Marrone A, Ciancetta A, et al. Targeting aquaporin function: Potent inhibition of aquaglyceroporin-3 by a gold-based compound. PlosOne. 2012;7(5):e37435
- Freisleben SKU, Hidayat J, Freisleben HJ, et al. Plasma lipid pattern and red cell membrane structure in β-thalassemia patients in Jakarta. Med J Indones. 2011;20(3):178–184
- Udyaningsih-Freisleben SK, Kurniati V, Prasetyo PB, et al. Isolated erythrocyte membranes of transfusion-dependent and non-transfused thalassemia patients in Jakarta, investigated by electron paramagnetic resonance spectroscopy. BioFactors. 2003;19(1,2):87–100
- Laksmitawati DR, Handayani S, Udyaningsih-Freisleben SK, et al. Iron status and oxidative stress in β-thalassemia patients in Jakarta. BioFactors. 2003;19(1,2):53–62
- Zanella A, Milani S, Fagnani G, et al. Diagnostic value of the glycerol lysis test. J Lab Clin Med. 1983;102(5):743–750
- Dotan Y, Lichtenberg D, Pinchuck I. Lipid peroxidation cannot be used as universal criterion of oxidative stress. Prog Lipid Res. 2004;43(3):200–207
- Sies H. Total antioxidant capacity: Appraisal of a concept. J Nutr. 2007;137(6):1493–1495